An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021319
Company: WAYLIS THERAP

Summary Review

Other Important Information from FDA

Products on NDA 021319

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
AVODART	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021319

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/20/2001	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21319lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21319_Duagen_approv.PDF https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21319_Duagen.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/30/2020	SUPPL-32	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021319s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021319Orig1s032ltr.pdf
09/10/2013	SUPPL-30	Manufacturing (CMC)		Label is not available on this site.
04/30/2013	SUPPL-29	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021319Orig1s028,s029ltr.pdf
04/30/2013	SUPPL-28	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021319Orig1s028,s029ltr.pdf
06/27/2012	SUPPL-27	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021319s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021319s027ltr.pdf
06/09/2011	SUPPL-25	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021319s023,s025ltr.pdf
06/09/2011	SUPPL-23	Efficacy-New Indication	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021319s023,s025ltr.pdf
09/09/2010	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021319s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021319s022ltr.pdf
06/15/2010	SUPPL-18	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021319s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021319s018ltr.pdf
03/31/2008	SUPPL-15	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021319s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021319s015ltr.pdf
06/19/2008	SUPPL-14	Efficacy-New Indication	Label (PDF) Letter (PDF) Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021319s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021319se1-014ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2008/021319se1-014_SUMR.pdf
12/23/2005	SUPPL-9	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021319s009rev2.pdf
09/14/2004	SUPPL-8	Efficacy-Labeling Change With Clinical Data	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21319s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21319s008ltr.pdf
08/05/2004	SUPPL-7	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21319s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21319s007ltr.pdf
03/12/2004	SUPPL-5	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21319slr005ltr.pdf
12/31/2002	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
10/09/2002	SUPPL-2	Manufacturing (CMC)-Packaging		Label is not available on this site.
10/09/2002	SUPPL-1	Efficacy-New Indication	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21-319s1lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21319se1-001ltr.pdf

Labels for NDA 021319

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/30/2020	SUPPL-32	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021319s032lbl.pdf
04/30/2013	SUPPL-29	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf
04/30/2013	SUPPL-28	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf
06/27/2012	SUPPL-27	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021319s027lbl.pdf
06/09/2011	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf
06/09/2011	SUPPL-23	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s023s025lbl.pdf
09/09/2010	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021319s022lbl.pdf
06/15/2010	SUPPL-18	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021319s018lbl.pdf
06/19/2008	SUPPL-14	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021319s014lbl.pdf
03/31/2008	SUPPL-15	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021319s015lbl.pdf
09/14/2004	SUPPL-8	Efficacy-Labeling Change With Clinical Data	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21319s008lbl.pdf
08/05/2004	SUPPL-7	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21319s007lbl.pdf
10/09/2002	SUPPL-1	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21-319s1lbl.pdf
11/20/2001	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21319lbl.pdf

Therapeutic Equivalents for NDA 021319

AVODART

CAPSULE;ORAL; 0.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
AVODART	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	Yes	AB	021319	WAYLIS THERAP
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	206373	ACELLA
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	204376	ADAPTIS
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	203118	AMNEAL PHARMS
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	206574	ASCENT PHARMS INC
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	202660	AUROBINDO PHARMA LTD
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	090095	BARR
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	200899	CHARTWELL
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	209909	HUMANWELL PURACAP
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	204262	STRIDES PHARMA
DUTASTERIDE	DUTASTERIDE	0.5MG	CAPSULE;ORAL	Prescription	No	AB	204373	ZYDUS LIFESCIENCES

Top